Helper cell-independent antitumor activity of potent CD8(+) T cell epitope peptide vaccines is dependent upon CD40L

Peptide vaccines derived from CD8(+) T-cell epitopes have shown variable efficacy in cancer patients. Thus, some peptide vaccines are capable of activating CD8(+) T-cell responses, even in the absence of CD4(+) T-cell epitopes or dendritic cell (DC)-activating adjuvants. However, the mechanisms unde...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Llopiz, Diana, Huarte, Eduardo, Ruiz, Marta, Bezunartea, Jaione, Belsúe, Virginia, Zabaleta, Aintzane, Lasarte, Juan J, Prieto, Jesús, Borrás-Cuesta, Francisco, Sarobe, Pablo
Format: Artigo
Idioma:Inglês
Publicat: Landes Bioscience 2013
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3897504/
https://ncbi.nlm.nih.gov/pubmed/24498563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.27009
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars